Star Scientific, Inc. (NASDAQ: CIGX) has announced that the company to initiate the launch of Anatabloc(TM), a dietary supplement that is designed to support the immune system in maintaining healthy levels of inflammation. Anatabloc(TM), developed by the company's Rock Creek Pharmaceuticals subsidiary, is being launched via a dedicated website (www.anatabloc.com) where the product can be purchased. The product also can be purchased through a toll-free customer center (1-800-778-2031).
Anatabloc(TM) contains the dietary ingredient anatabine citrate. Anatabine is an alkaloid that is found in a variety of plants in the Solinaceae family including the tobacco plant as well as in eggplant, green peppers and green tomatoes. Anatabine citrate, combined with Vitamins A and D3, is believed to assist the body in maintaining anti-inflammatory support. A provisional patent application has been filed with the US Patent & Trademark Office for the Anatabloc(TM) product.
As the company noted in an earlier release, a human trial examining the role of Anatabloc(TM) in subjects who are at risk for excessive inflammation is currently being conducted (the FIint study). Another human trial, conducted by Rock Creek, will begin in late September, and the company expects that a third trial, to be overseen by researchers at the University of Pisa, will begin during the fourth quarter.
A group of Richmond area physicians and healthcare providers are gathering at the Virginia Governor's mansion today to learn more about the state of the research on Anatabloc(TM). The lead researchers who have overseen pre-clinical studies will discuss the results of testing with this group. They will be joined by researchers from the University of Virginia Medical School and the VCU Medical Center who also are interested in studying further potentials for Anatabloc(TM). Rock Creek has solicited research proposals from these institutions, and expects to issue planning grants for the preparation of full research proposals. The company anticipates that several of the planning grants will be announced. Jonnie R. Williams, Star Scientific CEO, commented: "The tobacco plant led the way in growing the economy of the Commonwealth of Virginia 400 years ago. As a Virginia-based company, we now want to lead the way in understanding how the tobacco plant can yield important benefits to human health."
Anatabloc(TM) is the second dietary supplement to be developed by Rock Creek. The company's first product, CigRx®, was introduced in early August 2010. CigRx® contains the dietary ingredients anatabine citrate and an extract of yerba mate, and provides smokers with a non-nicotine, non-tobacco alternative when they have the urge to light a cigarette. In addition to a dedicated website (www.cigrx.com) and purchase portal via Amazon.com, the CigRx® retail presence has expanded significantly in the past two months. It now is available at all Richmond-Tri City CVS/Pharmacy stores as well as in roughly 500 stores in independent retail and convenience stores in New England.
Curtis Wright, MD, MPH, Senior VP and Scientific Director with Rock Creek, commented, "It is exciting and professionally satisfying to see the research of the past few years resulting not only in new discoveries and intellectual property, but to now be manifest in new products of real benefit to smokers and non-smokers alike."
About Star Scientific
Star Scientific is a technology-oriented company with a mission to reduce the harm associated with tobacco at every level. It is engaged in the development of dissolvable smokeless tobacco products that deliver fewer carcinogenic toxins, principally through the utilization of the innovative StarCured® tobacco curing technology. Its subsidiary, Rock Creek Pharmaceuticals, Inc., is involved in the development of nutraceuticals as well as products to address neurological and mood disorders. Rock Creek Pharmaceuticals has scientific and research offices in Gloucester, MA, and a regulatory office in Washington, D.C. Star Scientific has a Corporate and Sales Office in Glen Allen, VA, an Executive, Scientific & Regulatory Affairs office in Bethesda, MD, and a manufacturing facility in Chase City, VA.